26 June 2026
Publication series: Avian influenza overview
Between 28 February and 4 June 2026, 949 highly pathogenic avian influenza (HPAI) A(H5) virus detections were reported in domestic (186) and wild (763) birds in 30 countries in Europe.
Abstract
The downward trend in the number of detections observed at the end of the previous reporting period continued and is expected to persist throughout the summer.
While the number of HPAI A(H5N1) outbreaks in domestic birds remained at a low level, except in a few countries, A(H9N2) virus of clade G5.5 was detected in poultry in Europe for the first time.
Following the intense circulation of HPAI viruses in waterfowl in recent months, sporadic detections were reported in mammals, particularly in wild carnivores, including the detection of A(H5N5) virus in a polar bear and a walrus in Norway.
Outside Europe, the focus of HPAI virus detections shifted from North to South America, where a large number of outbreaks and mortality events in swans were reported.
Between 28 February and 4 June 2026, 19 cases of avian influenza virus infection were publicly reported in humans (including three fatal cases) in six countries and territories: Bangladesh (two cases with A(H5N1), one fatal), Cambodia (three cases with A(H5N1), one fatal), India (one case with A(H5N1)), Italy (one imported case with A(H9N2)), China (10 A(H9N2) cases and one fatal A(H5N6) case), and Taiwan (one A(H7N7) case).
Most human cases reported exposure to poultry or a poultry environment prior to detection or onset of illness.
Human infections with avian influenza viruses remain rare and no sustained human-to-human transmission has been documented.
The risk posed by avian influenza A(H5N1) clade 2.3.4.4b viruses currently circulating in Europe remains low for the general public in the European Union/European Economic Area (EU/EEA) and low-to-moderate for those occupationally or otherwise exposed to infected animals or contaminated environments.
Source:
Link: https://www.ecdc.europa.eu/en/publications-data/avian-influenza-overview-march-may-2026
____
No comments:
Post a Comment